Abstract
As part of the assessment of the biological properties of a new bone cement (London Hospital cement) which contains poly(ethylmethacrylate) and n-butylmethacrylate, the monomer (n-butylmethacrylate) has been compared in toxicity studies with methylmethacrylate monomer, as used in conventional bone cement. N-butylmethacrylate monomer had an LD50 of 1.0 to 1.2 ml kg−1 and was therefore only slightly more toxic than methylmethacrylate monomer (LD50 1.2 ml kg−1) when injected intraperitoneally into mice. It did not have any more significant cardiorespiratory depressive effect on intravenous infusion into rabbits, either in single or cumulative doses, when compared with methyl monomer (repeated infusions in 12 rabbits). Both monomers caused a transient bradycardia, tachypnoea, raised central venous pressure and arterial hypotension in low doses with rapid recovery, though the effects were sustained at higher cumulative doses of 60 mg kg−1 and above. These results demonstrate that n-butylmethacrylate monomer does not differ significantly in toxicity from the monomer used in conventional cement and can therefore be used as a component in the new material.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Materials Science: Materials in Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
